Omega Healthcare Investors (NYSE:OHI) Releases FY 2026 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 3.190-3.250 for the period, compared to the consensus EPS estimate of 3.070. The company issued revenue guidance of -.

Omega Healthcare Investors Stock Performance

NYSE OHI traded up $0.24 during trading on Thursday, hitting $46.97. The company’s stock had a trading volume of 647,532 shares, compared to its average volume of 2,045,183. The company has a quick ratio of 5.04, a current ratio of 5.04 and a debt-to-equity ratio of 0.78. The firm has a 50 day moving average price of $46.37 and a 200 day moving average price of $44.78. The firm has a market cap of $13.99 billion, a P/E ratio of 24.33, a price-to-earnings-growth ratio of 2.09 and a beta of 0.59. Omega Healthcare Investors has a 52 week low of $35.08 and a 52 week high of $49.14.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.07). The business had revenue of $322.96 million during the quarter, compared to the consensus estimate of $266.12 million. Omega Healthcare Investors had a net margin of 49.59% and a return on equity of 11.35%. The firm’s revenue was up 16.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.75 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Equities research analysts forecast that Omega Healthcare Investors will post 3.06 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, May 4th will be issued a $0.67 dividend. The ex-dividend date of this dividend is Monday, May 4th. This represents a $2.68 dividend on an annualized basis and a yield of 5.7%. Omega Healthcare Investors’s dividend payout ratio is 138.86%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. BMO Capital Markets lowered shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 price target on the stock. in a research report on Friday, January 9th. Scotiabank lifted their target price on Omega Healthcare Investors from $45.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Tuesday, April 21st. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $45.00 to $47.00 and gave the company an “equal weight” rating in a report on Thursday, March 26th. Finally, The Goldman Sachs Group assumed coverage on Omega Healthcare Investors in a research report on Friday, January 9th. They issued a “buy” rating and a $54.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and a consensus price target of $47.83.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors have recently added to or reduced their stakes in OHI. Compound Planning Inc. lifted its position in shares of Omega Healthcare Investors by 6.8% during the 4th quarter. Compound Planning Inc. now owns 19,207 shares of the real estate investment trust’s stock worth $852,000 after buying an additional 1,220 shares during the period. Invesco Ltd. grew its position in Omega Healthcare Investors by 8.6% in the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock valued at $238,059,000 after acquiring an additional 424,024 shares during the period. Corient Private Wealth LLC raised its stake in Omega Healthcare Investors by 247.2% during the fourth quarter. Corient Private Wealth LLC now owns 208,473 shares of the real estate investment trust’s stock worth $9,244,000 after acquiring an additional 148,434 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in shares of Omega Healthcare Investors by 23.2% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 154,446 shares of the real estate investment trust’s stock worth $6,848,000 after purchasing an additional 29,045 shares during the last quarter. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Omega Healthcare Investors during the 4th quarter worth about $332,000. 65.25% of the stock is owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.